Mood Disorders Flashcards

1
Q

Prevalence on bipolar and depression

A

Bipolar I- m=f
Bipolar II-and MDD f>m

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

DSM 5 for depressive episode

A

Occurrence of 2 weeks or more of depressed mold and presence of 4/8 of following
Sleep alteration
Appetite alteration
Diminished interest or anhedonia
Decreased concentration
Low energy
Guilt
Psychomotor changes
Suicidal thoughts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MDD

A

If no manic or hypo manic episode in last identified then diagnose MDD
Subtypes
Atypical features eg jncrease sleep and appetite along with heightened mood
Melancholic features along with marked psychomotor retardation and anhedonia
Psychotic features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Depression triads

A

Core symptoms-low mood,anergia,anhedonia
Psychological symptoms-the world,oneself,the future
Biological symptoms-sleep,appetite,libido

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cycle of low mood

A

What’s the point
Feel low flat and irritable
Exhaustion
Lie in bed all day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cycle of high mood

A

I’m the best I can DI anything
Elation and excitement
Physiological symptoms cause increased energy and race sensation
Impulsive behavior and increased activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mania

A

Euphoric or irritable mood with 3/7
Decreased need for sleep
Distractibilitu
Grandiosity
Flight of ides or racing thoughts
Increased talkativeness or pressured speech
Increased goal directed activity or psychomotor agitation
Impulsive behavior

If present for minimum 1 week with functional impairment a manic episode diagnosed (type I bipolar disorder)

If present for minimum 4 days wihout notable functional impairment a hypomanic episode discovered

If not a single manic episode has occurred but only hypomanic with one major depressive episode then type II diagnosed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Unspecified bipolar disorder

A

If manic episodes occur for less than 4 days and no other specific threshold met rhen hypomanic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When can’t hypomania be diagnosed

A

If psychotic features are present
If a patient is hospitalized it’s manic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Long term status of bipolar disorder

A

Majority of time symptoms free
Then depressive symptoms
Manic/hypomanic
Cycling/mixed symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bipolar vs unipolar disorders differences

A

Bipolar illness had an early age of onset (mean age of about 19 years vs about the late 20s for unipolar depression)
Shorter depressive episodes (in average 3m or less in bipolar vs in average 6-12m in unipolar).
Recurrent course (more frequent episodes in bipolar than unipolar illness, with rapid cycling, defined as four or more episodes yearly happening in about 25% of bipolar illness cases, but in <1% of unipolar depression cases).
Genetic specificity (manic episodes were found in families of persons with manic episodes, but not in families of persons with unipolar depression).
Differential treatment (antidepressants for unipolar depression vs neuroleptics and lithium for mania)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bipolar and unipolar similarities

A

MDD is commonly diagnosed in children, far below the mean onset of the late 20s.

Brief depressive episodes that occur multiple times yearly are diagnosed in patients with MDD commonly, whereas such course of illness should be rare if MDD was a different illness than bipolar disorder.

Genetic studies have found high rates of depressive episodes, without mania, in persons with bipolar illness, and also frequent occurrence of bipolar illness in relatives of those with unipolar depression.

Treatment now overlaps considerably, with neuroleptic agents proven effective not only for mania, but also for depression, both in bipolar and unipolar types.

Lithium has been well known to be effective not only for mania, but also for depression, both in bipolar and unipolar types.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Basic pharmacology of tryptamine psychedelics

A

Psilocin/psilocybin oral 4-5 hours and IV 1 hour
DMT/ayahuasca oral 4-5 hours and smoke or Iv 10-20 mins
LSD oral 10-12 hours and IV 1 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Psychedelic

A

Safety-non addictive low physiological and bracing toxicity ,good therapeutic index

Risks-dysphoria anxiety nausea headache hidden vs false memories

Safety weell established

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Monoamine deficiency hypothesis

A

Depressive syndromes arise from insufficient levels of monoamine neurotransmitters seratonin norepinephrine or dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indirect evidence for 5HT hypo function in depression

A

5-HT depletion by the antihypertensive drug reserpine could cause depression.

Clinically useful antidepressants all increase synaptic monoamine (some selectively 5-HT) concentrations.

Post-mortem evidence of reduced 5-HT levels in brainstem of individuals who committed suicide

Lower levels of 5-HT1A-receptors

Monoamine oxidase A increases in MDD

Blockade of serotonin synthesis by the tryptophan hydroxylase inhibitor p-chlorophenylalanine prevents the antidepressant effects of both MAOIs and TCAs (Shopsin 1975 & 1976)

Tryptophan depletion ( brain serotonin) triggers relapse in MDD successfully treated with SSRIs (Delgado 1999) or cognitive behavioural therapy (CBT) (Smith 1997).

Monoamine depletion correlates with mood both in at risk and MDD in remission (Ruhe 2007) .

Depression-related traits; “pessimism” and “dysfunctional attitudes” in MDD, and traits “negativism” and “neuroticism” in healthy, related to 5-HT2A-receptor increase(? Serotonin decreases).

17
Q

Measuring neurotransmitter and receptors

A

PET imaging used
Compared to fmri it’s selective but invasive,radioactive and expensive with less optimal temporal and spatial resolution
Use pet to do baseline scan
Inject radioactive tracer which binds to receptors and quantifies how many receptors we have
Then give amphetamine which competes with substrate and repeat scan

18
Q

How do we measure 5HT

A

New method using a combination of an agonist radioligand 11C-CIMBI-36 and amphetamine as the pharma challenge works !!!

So now, 5-HT release can be measured in the living human brain